Study of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian Countries
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will be conducted with the aim of investigating the efficacy, safety and
tolerability of 10 mg/day Vortioxetine in Asian patients compared to an approved active
comparator (venlafaxine extended release 150 mg/day).